Seaport Therapeutics to present at 24th Annual Needham Virtual Healthcare Conference
Seaport Therapeutics presents at Stifel 2025 Virtual CNS Forum
Seaport presents at J.P. Morgan Healthcare Conference 2025
Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug Transport
Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesity
Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic Transport
SPT-320, a First-in-Class Prodrug of Agomelatine that Avoids
First-Pass Hepatic Metabolism via Lymphatic System Absorption
Clinician-administered assessments and impact on placebo response in recent major depressive disorder (MDD) clinical trials
First-in-human Translation of a Biomimetic Glyceride Prodrug Platform: Enabling Avoidance of First-pass Metabolism via Lymphatic Absorption
101 Seaport Blvd
Seaport Boston, MA 02210
General info: info@seaporttx.com
Media: publicrelations@seaporttx.com
